Lowell F. Satler

Showing 1-6 of 6 articles

Interventions for valvular disease

The adjunctive use of Angio-Seal in femoral vascular closure following percutaneous transcatheter aortic valve replacement

Kiramijyan S, Magalhaes M, Ben-Dor I, Koifman E, Escarcega R, Baker N, Torguson R, Okubagzi P, Bernardo N, Satler L, Pichard A, Waksman R

May 16, 2016 | 10.4244/EIJV12I1A16

The effect of complete percutaneous revascularisation with and without intravascular ultrasound guidance in the drug-eluting stent era

Magalhaes M, Minha S, Torguson R, Baker N, Escarcega R, Al Fazir O, Lipinski M, Chen F, Suddath W, Satler L, Pichard A, Waksman R

October 20, 2015 | 10.4244/EIJV11I6A124

Correlation between fractional flow reserve and intravascular ultrasound lumen area in intermediate coronary artery stenosis

Ben-Dor I, Torguson R, Gaglia M, Gonzalez M, Maluenda G, Bui A, Xue Z, Satler L, Suddath W, Lindsay J, Pichard A, Waksman R

June 30, 2011 | 10.4244/EIJV7I2A37

Impact of drug-eluting stent type on periprocedural myocardial necrosis

Wakabayashi K, Delhaye C, Mahmoudi M, Belle L, Ben-Dor I, Gaglia M, Suddath W, Satler L, Kent K, Pichard A, Lindsay J, Waksman R

May 17, 2011 | 10.4244/EIJV7I1A22

Relation between clopidogrel discontinuation and early cardiovascular events after percutaneous coronary intervention with drug-eluting stents

Lemesle G, Torguson R, Bonello L, de Labriolle A, Maluenda G, Ben-Dor I, Collins S, Syed A, Xue Z, Satler L, Pichard A, Waksman R

April 20, 2011

Hybrid strategy of a bare metal stent combined with a drug-eluting stent versus exclusive drug-eluting stent implantation for multivessel percutaneous coronary intervention

Syed A, Ben-Dor I, Li Y, Collins S, Torguson R, Wakabayashi K, Gonzalez M, Maluenda G, Delhaye C, Belle L, Gaglia M, Jr. J, Xue Z, Kaneshig K, Bernardo N, Kent K, Suddath W, Satler L, Pichard A, Lindsay J, Waksman R

April 20, 2011

1

Latest news

PCR London Valves Edition: state of the art on transcatheter treatment for tricuspid valve disease, a mini focus on TR; coronary access after TAVI and more…

November 19, 2021

STATE OF THE ART

Transcatheter treatment for tricuspid valve disease

Fabien Praz et al.

November 19, 2021

Long-term impact of OCT-assessed suboptimal stent deployment

Francesco Prati et al.

November 25, 2021

Percutaneous tricuspid valve annuloplasty: additional data and remaining questions

Nicole Karam et al.

November 23, 2021

Bioprosthetic valve fracture: haemodynamically effective but safe and clinically necessary?

Josep Rodés-Cabau et al.

November 23, 2021

Understanding the past, getting prepared for the future. (Going from in vivo to in vitro to in silico)

Patrick W. Serruys

November 23, 2021

Crush techniques for percutaneous coronary intervention of bifurcation lesions

Francesco Moroni et al.

November 18, 2021

Valvular disease